title: [Brazilian Diabetes Society consensus statement--intensive insulin therapy and insulin pump therapy].
abstract: This article reports the Brazilian Diabetes Society consensus statement on intensive insulin therapy and insulin pump therapy, arrived at during an update symposium held in 2003 for this specific purpose. The concepts underlying these modalities of diabetes treatment are outlined, their fundaments are given, and practical issues about their indications, feasibility, limits, techniques and cost-benefit relationships are analyzed. The techniques comprise the suggested self-monitoring schedules and the insulin doses, types, forms of administration and correction factors used in each modality of intensive treatment, for both type 1 and 2 diabetes. The roles of SBD in the implementation of these treatments and of the different professionals involved are discussed and commented. The conclusions are based on consensual answers to some orienting questions formulated during the symposium's presentation.
authors.affiliation: Sociedade Brasileira de Diabetes.
authors.forename: Domingos
authors.initials: D
authors.lastname: Malerbi
authors.forename: Durval
authors.initials: D
authors.lastname: Damiani
authors.forename: Nelson
authors.initials: N
authors.lastname: Rassi
authors.forename: Antonio Roberto
authors.initials: AR
authors.lastname: Chacra
authors.forename: Edgar D'Avila
authors.initials: ED
authors.lastname: Niclewicz
authors.forename: Ruy Lyra da
authors.initials: RL
authors.lastname: Silva Filho
authors.forename: Sergio Atala
authors.initials: SA
authors.lastname: Dib
mesh_terms: D015190:Blood Glucose Self-Monitoring; D001938:Brazil; D003362:Cost-Benefit Analysis; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy* / Q000191:economics; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D015918:Infusion Pumps, Implantable / Q000191:economics; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems; D012955:Societies, Medical
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin